1 / 9

Human M. tuberculosis infection/ disease: classical pathology and immunology (Slide -1)

NIAID-DMID: -AI70022. Human M. tuberculosis infection/ disease: classical pathology and immunology (Slide -1). W. Henry Boom, M.D. Tuberculosis Research Unit (TBRU) Case Western Reserve University. Cattle Prod 1950. Route(s) of Infection & Natural Course (Slide 0).

arvid
Download Presentation

Human M. tuberculosis infection/ disease: classical pathology and immunology (Slide -1)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NIAID-DMID: -AI70022 Human M. tuberculosis infection/ disease: classical pathology and immunology (Slide -1) W. Henry Boom, M.D. Tuberculosis Research Unit (TBRU) Case Western Reserve University Cattle Prod 1950

  2. Route(s) of Infection & Natural Course (Slide 0) • small vs. large droplet aerosol • repeated exposure • ?infectious dose (animals: 1-10 CFU) • ?repeated infection IO PROGRESSIVE: PEDS.+IMMUNOCOMP. (5%) REACTIVATION/ADULTS (5-10%) Bacterial Load INFECTION (90+%) Time (mos-yrs)

  3. Pulmonary Tuberculosis(slide 1) • Cough (+/-RBC), Wt. Loss, Night sweats • 109-1011 CFU • Diagnosis: Sputum Smear/Culture (<50% paucibacillary) • Pathology: Caseating Granulomas, Necrosis, Cavitation (?Host or Microbe) • Death: • Cachexia • Respiratory Failure • Dissemination (miliary, meningitis) • Massive Hemoptysis http://library.med.utah.edu/WebPath

  4. c l a s s I M H C c l a s s I I M H C C D 4 C D 8 T c e l l T c e l l - T C R a b M F - T C R a b Phos. Ag g - T C R d gd C D 1 r e s t r i c t e d T c e l l s D N T C R a b T c e l l CD25+ CD4 T cell Immunology of M. tuberculosis infection and disease (slide 2) INFECTION • TLR’s • Chemokines • Cytokines • Antigens • T cell subsets • Effector mech. • Immune evasion REACTIVATION Bacterial Load Failure (Immunopathogenesis?) Innate Adaptive

  5. Known: Adaptive immunity CD4+ T cell TNF-alpha IFN-gamma IL-12 Unknown: Genetics: which ones/stage (IFNgamma/IL12 pathway, NRAMP1, TNFalphaR, etc.) TLRs: which ones/when Chemokines: same (MCP1)? What does IFN-gamma do? Immunology of the lung: why so slow? Antigens matter: which ones, when, where? Dogma: “Immuno-pathogenesis” (HIV: cavitation related to CD4, but mortality still high) CD8’s critical, cause of BCG failure It is all about cytokines (cytokine interventions have failed) Now it’s Tregs, Th17……… Unknown unknowns: TLRs in last century Why all T cell vaccines have failed so far (TB, HIV)? TNF-a, IL-12 T M IFN-g “Known knowns, known unknowns, unknown unknowns” and dogma for immunology of human TB (slide 3, “adapted from Donald Rumsfeld ‘03”)

  6. Panel III: Immune Relevancy Sacred “cows”, questions and other musings

  7. Questions to consider….. • Can host responses/markers tell us when infection progresses to disease? • Or is it detecting something from MTB that tells us CFUs are increasing? • Is Th1 vs. Th2 paradigm (still) useful? • Ineffectual/failed Th1 rather than Th2? • Balance of cytokines or do antigens matter? • For vaccines likely? For progression maybe not? For relapse/reinfection don’t know? • Evidence that host responses are responsible for pathology? • Aren’t granulomas in the right places good? Does it depend on the stage of infection? Can we intervene to prove it? • What’s up with the lungs? • Why the sluggish response? What is unique about the lungs as immune environment/sanctuary for MTB?

  8. How can natural/experimental infection in animals help with these questions? • Natural history of infection and progression to disease (many) • Transition between stages/markers of transition • Pathology-granuloma, caseation, cavitation (rabbit, guinea pig) • MTB mutants/host genetic variants that differ in induction of pathology with similar CFU • Role of innate vs. adaptive immunity (mouse, primate, bovine) • Models difficult to infect, innate KO’s • Genetics of different stages (mouse, bovine, fish, ?others) • Infection, progression, reactivation vs. relapse • Drug Treatment (mouse, rabbit, primate, fish) • Latent vs. active infection (penetration/efficacy, PK, ARV) • Vaccine (mouse, guinea pig, primate, bovine) • Infection, dissemination vs. re-activation • Co-pathogenesis-HIV or helminth co-infection (primate) • Maybe asking too much…….

More Related